Series D Round

$140.0M Jun 01, 2025

Funding Details

Grin Therapeutics is a healthcare startup focused on developing innovative therapies to improve patient outcomes. The company aims to leverage advanced technologies and research to create effective treatments for various medical conditions. This Series D funding round will be used to accelerate the development of their pipeline products and expand their clinical trials.

Confidence Score

Data extraction confidence: 90%

Participating Investors

No investors recorded for this funding round.

Related Tweets

No tweets found for this funding round.

Subscribe to receive the latest startup funding news and investment insights.

Almost done! Please tell us a bit about yourself.

Processing your request...

Check Your Email

We've sent a verification link to your email address. Please check your inbox and click the link to verify your subscription.

Didn't receive the email? Check your spam folder or click below to resend.

Already Subscribed

This email address is already subscribed to our updates. Thank you for your interest!